129 related articles for article (PubMed ID: 25172289)
1. A markerless deletion method for genetic manipulation of Burkholderia cenocepacia and other multidrug-resistant gram-negative bacteria.
Aubert DF; Hamad MA; Valvano MA
Methods Mol Biol; 2014; 1197():311-27. PubMed ID: 25172289
[TBL] [Abstract][Full Text] [Related]
2. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
Bazzini S; Udine C; Riccardi G
Appl Microbiol Biotechnol; 2011 Dec; 92(5):887-95. PubMed ID: 21997606
[TBL] [Abstract][Full Text] [Related]
3. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.
Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G
BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052
[TBL] [Abstract][Full Text] [Related]
4. The suhB gene of Burkholderia cenocepacia is required for protein secretion, biofilm formation, motility and polymyxin B resistance.
Rosales-Reyes R; Saldías MS; Aubert DF; El-Halfawy OM; Valvano MA
Microbiology (Reading); 2012 Sep; 158(Pt 9):2315-2324. PubMed ID: 22767545
[TBL] [Abstract][Full Text] [Related]
5. Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepacia.
Gislason AS; Choy M; Bloodworth RA; Qu W; Stietz MS; Li X; Zhang C; Cardona ST
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799222
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.
Scoffone VC; Spadaro F; Udine C; Makarov V; Fondi M; Fani R; De Rossi E; Riccardi G; Buroni S
Antimicrob Agents Chemother; 2014; 58(4):2415-7. PubMed ID: 24395233
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.
Sass A; Marchbank A; Tullis E; Lipuma JJ; Mahenthiralingam E
BMC Genomics; 2011 Jul; 12():373. PubMed ID: 21781329
[TBL] [Abstract][Full Text] [Related]
8. Cell envelope structural and functional contributions to antibiotic resistance in
Hogan AM; Motnenko A; Rahman ASMZ; Cardona ST
J Bacteriol; 2024 Apr; 206(4):e0044123. PubMed ID: 38501654
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics.
Sass A; Everaert A; Van Acker H; Van den Driessche F; Coenye T
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439968
[TBL] [Abstract][Full Text] [Related]
10. The BCESM genomic region contains a regulator involved in quorum sensing and persistence in Burkholderia cenocepacia J2315.
Van Acker H; De Canck E; Van Nieuwerburgh F; Sass A; Deforce D; Nelis HJ; Coenye T
Future Microbiol; 2014; 9(7):845-60. PubMed ID: 25156374
[TBL] [Abstract][Full Text] [Related]
11. Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.
Hogan AM; Scoffone VC; Makarov V; Gislason AS; Tesfu H; Stietz MS; Brassinga AKC; Domaratzki M; Li X; Azzalin A; Biggiogera M; Riabova O; Monakhova N; Chiarelli LR; Riccardi G; Buroni S; Cardona ST
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297366
[TBL] [Abstract][Full Text] [Related]
12. Emergence of carbapenemases in Gram-negative bacteria in Hamburg, Germany.
Hentschke M; Goritzka V; Campos CB; Merkel P; Ilchmann C; Lellek H; Scherpe S; Aepfelbacher M; Rohde H
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):312-5. PubMed ID: 21899979
[TBL] [Abstract][Full Text] [Related]
13. In-Frame and Unmarked Gene Deletions in Burkholderia cenocepacia via an Allelic Exchange System Compatible with Gateway Technology.
Fazli M; Harrison JJ; Gambino M; Givskov M; Tolker-Nielsen T
Appl Environ Microbiol; 2015 Jun; 81(11):3623-30. PubMed ID: 25795676
[TBL] [Abstract][Full Text] [Related]
14. Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia(†).
Hamad MA; Di Lorenzo F; Molinaro A; Valvano MA
Mol Microbiol; 2012 Sep; 85(5):962-74. PubMed ID: 22742453
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
Saeed A; Khatoon H; Ansari FA
Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
[TBL] [Abstract][Full Text] [Related]
16. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia.
Scoffone VC; Barbieri G; Buroni S; Scarselli M; Pizza M; Rappuoli R; Riccardi G
Trends Microbiol; 2020 Apr; 28(4):315-326. PubMed ID: 31932141
[TBL] [Abstract][Full Text] [Related]
17. Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells.
El-Halfawy OM; Valvano MA
PLoS One; 2013; 8(7):e68874. PubMed ID: 23844246
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
Drevinek P; Mahenthiralingam E
Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of action of auranofin analogs in
Maydaniuk DT; Martens B; Iqbal S; Hogan AM; Lorente Cobo N; Motnenko A; Truong D; Liyanage SH; Yan M; Prehna G; Cardona ST
Microbiol Spectr; 2024 Feb; 12(2):e0320123. PubMed ID: 38206016
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
